RxDoctor Payments Data

George Lawrence, MD

Family Medicine · Mountain Home, ARNPI 1245237528

Payments from drug & device makers

$1,915in general payments, 2019–2025

Across 110 payments — averaging $17.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$445
  • AbbVie$248
  • GSK$228
  • Pfizer$181
  • Astellas Pharma US Inc$159
  • Bayer$149
  • plus $505 from 15 others

What the payments were for

  • Food & beverage$1,78093%
  • Education$1347%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,915 in reported general payments places this provider in the 70th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$306,911
Medicare patients
683
Services billed
12,293

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban102$85,869
OzempicSemaglutide62$68,626
JardianceEmpagliflozin90$64,801
Trelegy ElliptaFluticasone/Umeclidin/Vilanter30$26,840
ShingrixVaricella-Zoster Ge/As01b/Pf70$15,745
MyrbetriqMirabegron25$13,897
ArexvyRsvpref3 Antigen/As01e/Pf33$10,527
LinzessLinaclotide15$8,896
Breo ElliptaFluticasone/Vilanterol21$7,857
PremarinEstrogens, Conjugated14$6,702
SymbicortBudesonide/Formoterol Fumarate21$4,971
CreonLipase/Protease/Amylase12$4,889
Levothyroxine Sodium524$4,119
Pantoprazole Sodium282$2,985
Albuterol Sulfate HfaAlbuterol Sulfate80$2,822

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin$181$92,571116 claims
Novo NordiskOzempic$15$68,62662 claims
Boehringer IngelheimJardiance$42$64,80190 claims
GSKTrelegy Ellipta, Shingrix, Arexvy, Breo Ellipta$228$60,968154 claims
AbbVieLinzess, Creon, Synthroid$248$15,58160 claims
Astellas Pharma US IncMyrbetriq$159$13,89725 claims
AstraZenecaSymbicort$15$4,97121 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Mountain Home

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →